¹The Multiple Marker Screening labs determine the gestational age based on the published tables of Hadlock and Daya.

1. Hadlock, F.P., Deter, R.L., Harrist. R.B., Park, S.K. (1982). Fetal biparietal diameter: a critical re-evaluation of the relation to menstrual age by means of real-time ultrasound. J Ultrasound Med 1(3):97–104. DOI: 10.7863/jum.1982.1.3.97
2. Daya, S. (1993) Accuracy of gestational age estimations by means of fetal crown-rump length measurement. Am J Obstet Gynecol 168(3 Pt 1):903–8. DOI: https://doi.org/10.1016/S0002-9378(12)90842-X

Indicate the racial origin of the oocyte (egg) provider, which is usually the pregnant individual. In cases of egg donation, indicate the racial origin of the oocyte (egg) provider, not that of the pregnant individual.

Racial origin information is needed because the concentrations of screening markers have been shown to vary depending on the racial origin. Therefore, a pregnant individual’s screening markers are adjusted based on the racial origin information provided.

Only the broad racial origins listed are needed for screening marker adjustment. The categories on this requisition are not inclusive of all the race categories commonly used as social descriptors in Ontario. 

Description / examples for each of the racial origin categories on the requisition:

• Asian: South Asian (E.g. East Indian, Pakistani, Bangladeshi, Sri Lankan, Indo-Caribbean etc.), East/Southeast Asian (e.g. Chinese, Korean, Japanese, Filipino, Indonesian, Thai) descent
• Black: African, Afro-Caribbean descent
• Indigenous: First Nations, Metis, Inuk/Inuit descent
• White: European, Middle Eastern descent (e.g. Arab, Persian, Afhgan, Egyptian, Lebanese, Turkish, Kurdish)
• Other: Another race category or mixed racial origin

Racial origin should be as accurate as possible and should reflect the individual’s ancestral background (which may or may not align with how the pregnant individual identifies), not simply their birth country. This information should be obtained directly from the pregnant individual whenever possible.

Example of question you can ask pregnant individuals:

In our society, people are often described by their race or racial background. For example, some people are considered “White”, “Black”, or “South Asian”. How would you identify or describe your racial background?

Indicate the pregnant individual’s weight, including units (pounds (lbs) versus kilograms (kg)), at the time when this requisition is completed. This information is used for screening marker adjustments. Ensure the weight that you document is accurate. A weight discrepancy of 5 or more pounds (2.3 kilograms) has a significant impact on the risk for trisomy 21 for pregnant individuals with a risk close to the screening cut-off. 

Example of questions you can ask if the weight is not obtained at the time of appointment:

• What do you think is your current weight? 
• Do you think the weight your provided is accurate within 5 pounds? 

The Last Menstrual Period (LMP) is not needed for eFTS. The crown-rump length measurement at the time of NT ultrasound is used instead of the LMP to establish the gestational age of the fetus.

Indicate if insulin-dependent Diabetes Mellitus was diagnosed prior to the individual’s current pregnancy. Individuals with insulin-dependent Diabetes Mellitus have been shown to have different concentrations of screening markers compared to those who do not have this diagnosis. Screening marker adjustments must be made to account for these differences.

No screening marker adjustments are made for pregnant individuals with a history of gestational diabetes or preexisting diabetes that is not managed with insulin.

Example of questions you can ask pregnant individuals:

• Do you have a diagnosis of diabetes? 
• Was the diabetes diagnosed before the current pregnancy?
• Do you use insulin to manage the diabetes? 

Indicate if the pregnant individual has smoked any amount of tobacco at any point in the current pregnancy. Individuals with a history of smoking tobacco in their current pregnancy have been shown to have different concentrations of screening markers compared to those who do not have this history. Screening marker adjustments must be made to account for these differences. 

If the requisition does not include information about the smoking history, the pregnant individual is considered a non-smoker. Due to lack of published data, pregnant individuals exposed to second-hand smoke are considered non-smokers. 

Example of question you can ask pregnant individuals:

Have you smoked any cigarettes at any point in the current pregnancy? 

If the pregnancy was conceived using in vitro fertilization (IVF), indicate the egg harvest date and date of birth of the egg donor (either self or non-self). If the egg donor's full date of birth is unknown, indicate the year of birth. If only the year of the donor date of birth is provided, July 1 of the provided year is used as the date.

This information is requested because the age of the egg at the date of delivery influences the enhanced First Trimester Screening risk. In addition, screening marker levels vary between IVF and natural conceptions, and screening marker adjustments must be made to account for these differences.

Examples of questions you can ask pregnant individuals:

• Did the current pregnancy happen through in vitro fertilization (IVF)? 
• What was the egg harvest date?
• Were your own eggs used for this pregnancy, or was there an egg donor involved? 
• Do you know the date of birth of the egg donor; at minimum, the year of birth?  

If a suspected or confirmed vanishing twin/co-twin demise is identified on the NT ultrasound, the sonographer / physician performing the scan checks off “Confirmed or suspected vanishing twin/co-twin demise identified on this U/S” in this section. Checking this box signifies to the MMS lab that NT + STS needs to be performed. The pregnant individual is to proceed with the blood draw, and upon receipt of the blood sample, the MMS lab notifies you of the next steps, which would be to arrange an STS blood draw between 14 weeks 0 days to 20 weeks 6 days (and 8 weeks after the estimated date of demise).

If a twin pregnancy is identified on the NT ultrasound, the sonographer / physician performing the scan checks off “Viable twin pregnancy identified on this U/S” in this section.  Checking off this box signifies to the MMS lab that this is a twin pregnancy, therefore eFTS cannot be performed. The pregnant individual is to proceed with the blood draw, and upon receipt of the blood sample, the MMS lab notifies you that First Trimester Screening for twin pregnancies has been discontinued in Ontario and that OHIP-funded NIPT should be ordered instead.